These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8997630)

  • 1. Iloperidone binding to human and rat dopamine and 5-HT receptors.
    Kongsamut S; Roehr JE; Cai J; Hartman HB; Weissensee P; Kerman LL; Tang L; Sandrasagra A
    Eur J Pharmacol; 1996 Dec; 317(2-3):417-23. PubMed ID: 8997630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone.
    Subramanian N; Kalkman HO
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):553-60. PubMed ID: 11999907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
    Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
    J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE; Janssen PM; Megens AA; Schotte A
    J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
    Kalkman HO; Subramanian N; Hoyer D
    Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).
    Strupczewski JT; Bordeau KJ; Chiang Y; Glamkowski EJ; Conway PG; Corbett R; Hartman HB; Szewczak MR; Wilmot CA; Helsley GC
    J Med Chem; 1995 Mar; 38(7):1119-31. PubMed ID: 7707315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
    Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA
    J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
    Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.
    Heuillet E; Petitet F; Mignani S; Malleron JL; Lavayre J; Néliat G; Doble A; Blanchard JC
    Eur J Pharmacol; 1996 Oct; 314(1-2):229-33. PubMed ID: 8957240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the novel antipsychotic iloperidone at human D2, D3, alpha 2C, 5-HT6, and 5-HT1A receptors.
    Kalkman HO; Feuerbach D; Lötscher E; Schoeffter P
    Life Sci; 2003 Jul; 73(9):1151-9. PubMed ID: 12818723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
    Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.
    Okun I; Tkachenko SE; Khvat A; Mitkin O; Kazey V; Ivachtchenko AV
    Curr Alzheimer Res; 2010 Mar; 7(2):97-112. PubMed ID: 19939222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
    Albers LJ; Musenga A; Raggi MA
    Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.
    Scheller D; Ullmer C; Berkels R; Gwarek M; Lübbert H
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):73-86. PubMed ID: 18704368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
    Lawler CP; Prioleau C; Lewis MM; Mak C; Jiang D; Schetz JA; Gonzalez AM; Sibley DR; Mailman RB
    Neuropsychopharmacology; 1999 Jun; 20(6):612-27. PubMed ID: 10327430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone.
    Mutlib AE; Klein JT
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
    Mutlib AE; Strupczewski JT; Chesson SM
    Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.